Timothy R. Wright served as the CEO of MiMedx Group, Inc. from May 2019 until March 2020, using his extensive experience in healthcare and pharmaceuticals to lead the company. Before joining MiMedx, he was a partner at Signal Hill Advisors,...
Timothy R. Wright served as the CEO of MiMedx Group, Inc. from May 2019 until March 2020, using his extensive experience in healthcare and pharmaceuticals to lead the company. Before joining MiMedx, he was a partner at Signal Hill Advisors, advising on strategic initiatives. He also held significant positions at M2Gen, a cancer informatics company, and at Teva Pharmaceutical Industries, focusing on mergers and acquisitions. Wright earned his Bachelor's of Science in Marketing from The Ohio State University and has been actively involved in organizations like Agenus, Inc. and the Ohio State Innovation Foundation. During his time at MiMedx, his total compensation reached over $5 million, reflecting his impact on the company's direction. Interestingly, his stock holdings fluctuated significantly, peaking at over $17 million in August 2021 and revealing his deep involvement with the company's performance. This experience gives him a unique insight into managing growth and health in a competitive industry.